Dear Shareholder

In the last couple of months, we have been tremendously busy evolving the company into its new business model. With the revenue £2.55m higher for the six months to 30 June 2022 compared to the period in 2021, it’s good timing to update you on some of those changes and ongoing developments.

In the last couple of months, we have been tremendously busy evolving the company into its new business model. With the revenue £2.55m higher for the six months to 30 June 2022 compared to the period in 2021, it’s good timing to update you on some of those changes and ongoing developments.

We have delisted the business from Canada and moved the company from Canada to Guernsey (UK) relisting on the AQSE as our main exchange- so in simple terms we are now a UK based Company. We have also completed a ’stock consolidation’ – we had over 364 million shares in the market, and through a 1 in 10 transaction have reduced the outstanding shares to 36 million. We have also been accepted onto the electronic trading platform ‘Hargreaves Lansdown which had previously been an issue.’  The reason for this change being:

It was made clear to the Directors the importance of being located in the UK to gain further interest from UK investors (both retail and institutional), regulated under UK supervision with a share position more proportionate to the size of our business. It was also important that investors were able to trade our shares electronically on the largest trading platform – Hargreaves Lansdown. These points have now been addressed and we are pleased to say this process is now complete.

We have also evidenced, since 2017, the entrepreneurial passion and capabilities of our team to maximise revenue streams whilst adapting to market conditions: CBD, Hand Sanitiser and now COVID and Blood Testing.

We continue to deliver PCR testing and lateral flow tests based on travel requirements, whilst driving Goodbody Health to be a major provider of diagnostic health and wellness testing in the UK and potentially internationally. 70% of our Goodbody clinics are offering blood and other diagnostic services. We provide the necessary information to allow a patient to make informed decisions on their health ‘Know More-Live Better.’

We continue to evolve our plans across several workstreams incorporating;

• Our on-going support of the NHS and GP Practices by migrating key observations and early diagnostics from the GP’s and into our clinics
• Our webstore
• Developing our proposition further with our Independent Community Health Providers such as Pharmacies, Dentists, Opticians
• Free standing display units – we continue to build up a national footprint as we roll out our units that sell our home test kits directly from an in clinic stand
• Growing a “Business-to-Business” proposition – employers with over 50 employees – testing their staff on a regular basis
• Developing our Affiliate Program – Gyms, Clubs, Ethnic Specific such as Chinese medicine efficacy

“We will continue to keep you updated on our progress and the workstreams that we have set in place. We see that now is the time to help not only the over pressured community healthcare providers but offering patients the much-needed information to make informed decisions on preventive health” Marc Howells, Chief Executive Officer.